Center on Society and Health, Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond.
Center on Society and Health, Virginia Commonwealth University School of Medicine, Richmond.
JAMA. 2019 Nov 26;322(20):1996-2016. doi: 10.1001/jama.2019.16932.
US life expectancy has not kept pace with that of other wealthy countries and is now decreasing.
To examine vital statistics and review the history of changes in US life expectancy and increasing mortality rates; and to identify potential contributing factors, drawing insights from current literature and an analysis of state-level trends.
Life expectancy data for 1959-2016 and cause-specific mortality rates for 1999-2017 were obtained from the US Mortality Database and CDC WONDER, respectively. The analysis focused on midlife deaths (ages 25-64 years), stratified by sex, race/ethnicity, socioeconomic status, and geography (including the 50 states). Published research from January 1990 through August 2019 that examined relevant mortality trends and potential contributory factors was examined.
Between 1959 and 2016, US life expectancy increased from 69.9 years to 78.9 years but declined for 3 consecutive years after 2014. The recent decrease in US life expectancy culminated a period of increasing cause-specific mortality among adults aged 25 to 64 years that began in the 1990s, ultimately producing an increase in all-cause mortality that began in 2010. During 2010-2017, midlife all-cause mortality rates increased from 328.5 deaths/100 000 to 348.2 deaths/100 000. By 2014, midlife mortality was increasing across all racial groups, caused by drug overdoses, alcohol abuse, suicides, and a diverse list of organ system diseases. The largest relative increases in midlife mortality rates occurred in New England (New Hampshire, 23.3%; Maine, 20.7%; Vermont, 19.9%) and the Ohio Valley (West Virginia, 23.0%; Ohio, 21.6%; Indiana, 14.8%; Kentucky, 14.7%). The increase in midlife mortality during 2010-2017 was associated with an estimated 33 307 excess US deaths, 32.8% of which occurred in 4 Ohio Valley states.
US life expectancy increased for most of the past 60 years, but the rate of increase slowed over time and life expectancy decreased after 2014. A major contributor has been an increase in mortality from specific causes (eg, drug overdoses, suicides, organ system diseases) among young and middle-aged adults of all racial groups, with an onset as early as the 1990s and with the largest relative increases occurring in the Ohio Valley and New England. The implications for public health and the economy are substantial, making it vital to understand the underlying causes.
美国的预期寿命没有跟上其他富裕国家的步伐,现在正在下降。
检查生命统计数据并回顾美国预期寿命和死亡率不断上升的历史;并从当前文献和对州一级趋势的分析中汲取见解,确定潜在的促成因素。
分别从美国死亡率数据库和疾病预防控制中心 Wonder 获得了 1959-2016 年的预期寿命数据和 1999-2017 年的特定死因死亡率数据。分析重点是中年死亡(25-64 岁),按性别、种族/民族、社会经济地位和地理区域(包括 50 个州)进行分层。研究了 1990 年 1 月至 2019 年 8 月发表的研究,这些研究检查了相关的死亡率趋势和潜在的促成因素。
1959 年至 2016 年间,美国的预期寿命从 69.9 岁增加到 78.9 岁,但自 2014 年以来连续三年下降。最近美国预期寿命的下降结束了自 20 世纪 90 年代开始的 25-64 岁成年人特定死因死亡率不断上升的时期,最终导致 2010 年开始的全因死亡率上升。2010-2017 年间,中年全因死亡率从 328.5 人/10 万增加到 348.2 人/10 万。到 2014 年,所有种族群体的中年死亡率都在上升,原因是药物过量、酗酒、自杀以及一系列器官系统疾病。中年死亡率的最大相对增幅出现在新英格兰(新罕布什尔州,23.3%;缅因州,20.7%;佛蒙特州,19.9%)和俄亥俄河谷(西弗吉尼亚州,23.0%;俄亥俄州,21.6%;印第安纳州,14.8%;肯塔基州,14.7%)。2010-2017 年间中年死亡率的增加与美国估计有 33307 例额外死亡有关,其中 32.8%发生在俄亥俄河谷的 4 个州。
美国的预期寿命在过去 60 年的大部分时间里都有所增加,但随着时间的推移,增长率放缓,自 2014 年以来预期寿命下降。一个主要的促成因素是所有种族的年轻和中年成年人特定死因(例如药物过量、自杀、器官系统疾病)死亡率的增加,早在 20 世纪 90 年代就开始出现,俄亥俄河谷和新英格兰的相对增幅最大。这对公共卫生和经济的影响是巨大的,因此了解其根本原因至关重要。